Boehringer Ingelheim
Boehringer Ingelheim is a biopharmaceutical company active in human and animal health. As a top investor in research and development, we develop innovative therapies to improve outcomes and enhance lives. Independent since our foundation in 1885, Boehringer takes a long term perspective to build a healthier and more sustainable tomorrow. NP-GB-107308 I April 2026 Boehringer Ingelheim Ltd. have provided funding towards this independent programme. Boehringer Ingelheim Ltd. has had no editorial input into or influence on the agenda or content of this meeting, beyond the Boehringer Ingelheim Ltd. sponsored session.